Researchers at Intermountain Health and CareCentra say a new study suggests artificial intelligence could significantly change how chronic lung diseases are managed. The focus is on chronic obstructive pulmonary disease, or COPD, and asthma, two of the most common long-term pulmonary conditions affecting millions of people worldwide.
According to the report, the AI technology was used to help streamline and strengthen patient care. That points to a growing role for digital tools in identifying needs earlier, improving care coordination and helping clinicians manage complex respiratory conditions more efficiently.
The study is being described as a game changer for COPD and asthma treatment because these illnesses often require ongoing monitoring and repeated adjustments in care. When treatment can be organized more effectively, patients may benefit from a more consistent approach to managing symptoms and long-term health risks.
The findings also add to wider interest in how AI can support healthcare systems facing heavy demand. For providers treating COPD and asthma, the Intermountain and CareCentra research suggests AI may become an increasingly important part of delivering better pulmonary care.
